235 related articles for article (PubMed ID: 27492974)
21. CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15.
Liu Y; Chen X; Xu Y; Yang T; Wang H; Wang Z; Hu Z; Chen L; Zhang Z; Wu Y
J Mol Med (Berl); 2024 Jan; 102(1):81-94. PubMed ID: 37987774
[TBL] [Abstract][Full Text] [Related]
22. Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87.
Huang CC; Wu DW; Lin PL; Lee H
Oncotarget; 2015 Apr; 6(11):8698-708. PubMed ID: 25826088
[TBL] [Abstract][Full Text] [Related]
23. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential.
Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q
Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs.
Park KH; Lee TH; Kim CW; Kim J
J Immunol; 2013 Jun; 190(12):6550-8. PubMed ID: 23690481
[TBL] [Abstract][Full Text] [Related]
25. Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells.
Yin X; Han S; Song C; Zou H; Wei Z; Xu W; Ran J; Tang C; Wang Y; Cai Y; Hu Q; Han W
Cell Oncol (Dordr); 2019 Aug; 42(4):459-475. PubMed ID: 31001733
[TBL] [Abstract][Full Text] [Related]
26. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo.
Hwang J; Kim CW; Son KN; Han KY; Lee KH; Kleinman HK; Ko J; Na DS; Kwon BS; Gho YS; Kim J
FEBS Lett; 2004 Jul; 570(1-3):47-51. PubMed ID: 15251437
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo.
Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Liu Z; Huang JA
Oncotarget; 2017 May; 8(19):30817-30829. PubMed ID: 28199217
[TBL] [Abstract][Full Text] [Related]
28. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
[TBL] [Abstract][Full Text] [Related]
29. CCR1-mediated STAT3 tyrosine phosphorylation and CXCL8 expression in THP-1 macrophage-like cells involve pertussis toxin-insensitive Gα(14/16) signaling and IL-6 release.
Lee MM; Chui RK; Tam IY; Lau AH; Wong YH
J Immunol; 2012 Dec; 189(11):5266-76. PubMed ID: 23125416
[TBL] [Abstract][Full Text] [Related]
30. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells.
Deng H; Ravikumar TS; Yang WL
Cancer Lett; 2009 Aug; 281(2):220-31. PubMed ID: 19321257
[TBL] [Abstract][Full Text] [Related]
32. Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15.
Huang FJ; Zhou XY; Ye L; Fei XC; Wang S; Wang W; Ning G
BMC Cancer; 2016 Feb; 16():98. PubMed ID: 26875556
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
34. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
35. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
Menu E; De Leenheer E; De Raeve H; Coulton L; Imanishi T; Miyashita K; Van Valckenborgh E; Van Riet I; Van Camp B; Horuk R; Croucher P; Vanderkerken K
Clin Exp Metastasis; 2006; 23(5-6):291-300. PubMed ID: 17086356
[TBL] [Abstract][Full Text] [Related]
36. Keeping out the bad guys: gateway to cellular target therapy.
Kitamura T; Taketo MM
Cancer Res; 2007 Nov; 67(21):10099-102. PubMed ID: 17974948
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
38. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth.
Perurena N; Zandueta C; Martínez-Canarias S; Moreno H; Vicent S; Almeida AS; Guruceaga E; Gomis RR; Santisteban M; Egeblad M; Hermida J; Lecanda F
J Hematol Oncol; 2017 Jan; 10(1):23. PubMed ID: 28103946
[TBL] [Abstract][Full Text] [Related]
39. [Correlations of chemokine receptor CCR1 expression with metastasis of lymph nodes in colorectal carcinoma tissues].
Ma JA; Qiu ZH; Pei HP
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):714-5. PubMed ID: 19664396
[TBL] [Abstract][Full Text] [Related]
40. Hemofiltrate CC chemokines with unique biochemical properties: HCC-1/CCL14a and HCC-2/CCL15.
Forssmann U; Mägert HJ; Adermann K; Escher SE; Forssmann WG
J Leukoc Biol; 2001 Sep; 70(3):357-66. PubMed ID: 11527984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
